Three main concepts were incorporated: (i) the condition of interest (cerebral ischemia and ischemic stroke), (ii) interventions (antioxidant peptides, peptidomimetics, and small molecules), and (iii) outcomes (histology, Nissl, TUNEL, NeuN, and neuroprotection). This evidence concerns the gene RBFOX3 and Cerebral ischemia.